第二届全球技术创新大赛AI+医疗专题赛

参赛指南

一、参赛对象

聚焦AI与医疗健康深度融合细分领域，以“智医融合·创享健康”为核心，围绕医疗健康领域临床痛点、产业升级需求，重点征集具身智能与智慧手术机器人、医疗大模型与数据、AI+药物研发、智慧健康管理与主动健康四大方向优质科创项目。

二、参赛要求

项目主申请人应同时符合以下条件：

1.年龄一般不超过50周岁；

2.取得硕士及以上学位；

3.为企业主要创始人、第一大股东，股份不低于15%；

4.拥有项目相关的自主知识产权或掌握核心技术。

三、参赛赛题

赛道一：具身智能与智慧手术机器人

核心定位：聚焦手术精准化、微创化、智能化需求，突破传统手术对医生经验的高度依赖，通过具身智能与机器人技术提升手术安全性与效率，降低手术创伤与并发症发生率。

征集方向：手术机器人(含骨科、泌尿外科、神经外科、眼科等专科手术机器人)、医疗具身智能(Embodied AI)、人机协作手术系统、微创介入机器人、术中导航与精准操作设备、手术机器人耗材创新等方向创新项目。

赛道二：医疗大模型与数据

核心定位：聚焦医疗数据治理、安全合规与高效利用，依托大模型技术构建多模态医疗数据智能处理、知识计算与临床应用体系，解决医疗数据碎片化、标注成本高、隐私风险大、价值挖掘不足等痛点，打造安全、高效、可规模化的医疗数据智能服务能力。

征集方向：医疗大模型(Med-GPT)、医疗多模态数据大模型、医疗数据治理与隐私计算平台、医疗数据安全共享技术、医疗数据标注与质量管控、医学RAG知识库、医学文献智能分析、临床数据智能挖掘、数字疗法数据引擎、医疗数据要素流通与交易服务、多模态医学影像诊断系统(覆盖CT、MRI、超声、病理等)等方向创新项目。

赛道三：AI+药物研发

核心定位：依托人工智能技术赋能新药发现、靶点挖掘、分子设计、临床试验与安全性评价，大幅缩短研发周期、降低研发成本、提升药物研发成功率，聚焦AI驱动的创新药、改良型新药、医疗器械及耗材相关药物研发，打造AI赋能医药创新的核心竞争力。

征集方向：AI驱动药物靶点发现、AI分子生成与虚拟筛选、AI药物晶型预测、AI药代动力学及毒理学预测、AI辅助临床试验设计与患者招募、AI老药新用、AI多模态药物研发大模型、AI驱动医药研发数据平台、AI辅助药物合成工艺优化等方向创新项目。

赛道四：智慧健康管理与主动健康

核心定位：推动健康管理从“被动治疗”向“主动预防”转型，构建全周期、个性化健康管理体系，降低慢性病发生率与医疗负担。

征集方向：健康监测可穿戴设备(含生理指标实时监测、慢性病管理设备)、预测性医疗诊断系统、人体数字孪生平台、银发经济适老健康产品、慢性病智能管理系统、健康风险预警与干预方案、主动健康服务平台等方向创新项目。

四、报名方式

可选择以下任一方式完成报名。

1.大赛官网在线报名：https://reg.gticcn.com/business/

2.专题赛网站在线报名：https://v.wjx.cn/vm/rSYaUMW.aspx

五、赛事奖励

1.赛事将按整体赛事规则分赛道设置奖项，所有奖金均在获奖项目落地鹿城区后予以发放。

一等奖：奖金15万元*1名

二等奖：奖金10万元*2名

三等奖：奖金5万元*3名

2.参赛补贴：大赛组委会将为前来温州市鹿城区参加总决赛的项目提供往返交通补贴(补贴标准为欧美地区最高10000元/人次、亚洲地区最高3500元/人次、国内最高2000元/人次，省内地区最高1000元/人次，国际差旅要求7日内入境到温，国内差旅要求3日内到温，仅限报销经济舱)、免费食宿等。

　　The 2nd Global Technology Innovation Competition AI + Healthcare Special Competition

EVENT GUIDE

Ⅰ.ELIGIBILITY

The AI + Healthcare Special Track centers on the deep integration of artificial intelligence and healthcare, centered on the theme “Intelligent Healthcare Integration?Creating a Healthier Future”. It targets clinical pain points and industrial upgrading demands in the healthcare industry, calling for high-quality sci-tech innovation projects falling into four core categories: Embodied Intelligence and Intelligent Surgical Robotics，Medical Foundation Models and Data，AI + Drug Discovery and Development，Smart Health Management and Proactive Health.

Ⅱ.REQUIREMENTS

The lead applicant shall satisfy all the criteria below:

1.Be aged 50 or below;

2.Hold a Master’s degree or higher;

3.Serve as the core founder and largest shareholder of the enterprise, holding no less than 15% equity;

4.Own independent intellectual property rights or proprietary core technologies relevant to the project.

Ⅲ.COMPETITION TRACKS

Track 1: Embodied Intelligence and Intelligent Surgical Robotics

Focus: Focusing on the needs for greater precision, minimally invasive procedures, and intelligent surgery, this track aims to overcome the high reliance on physicians’ experience in traditional surgery. Through embodied intelligence and robotics technologies, it seeks to improve surgical safety and efficiency while reducing surgical trauma and the incidence of complications.

Areas of Solicitation:Innovative projects in surgical robotics (including orthopedic, urological, neurosurgical, ophthalmic, and other specialty surgical robots), medical embodied AI, human–robot collaborative surgical systems, minimally invasive interventional robots, intraoperative navigation and precision surgical equipment, surgical robot consumables, and related fields.

Track 2: Medical Foundation Models and Data

Focus: Focusing on medical data governance, security and compliance, and efficient utilization, this track aims to leverage foundation models to build intelligent systems for multimodal medical data processing, knowledge computing, and clinical applications. It addresses challenges such as fragmented medical data, high annotation costs, privacy risks, and insufficient value extraction, with the goal of developing secure, efficient, and scalable intelligent medical data services.

Areas of Solicitation:Innovative projects in medical foundation models (Med-GPT), multimodal medical data foundation models, medical data governance and privacy-preserving computing platforms, secure medical data-sharing technologies, medical data annotation and quality control, medical RAG knowledge bases, intelligent medical literature analysis, intelligent clinical data mining, data engines for digital therapeutics, medical data exchange and transaction services, and multimodal medical imaging diagnostic systems covering CT, MRI, ultrasound, pathology, and other modalities.

Track 3: AI + Drug Discovery and Development

Focus: Leveraging AI to empower drug discovery, target identification, molecular design, clinical trials, and safety evaluation, this track aims to significantly shorten R&D cycles, reduce development costs, and improve the success rate of drug development. It focuses on AI-driven innovative drugs, improved new drugs, and drug development related to medical devices and consumables, with the goal of building core competitiveness in AI-enabled pharmaceutical innovation.

Areas of Solicitation: Innovative projects in AI-driven drug target discovery, AI molecular generation and virtual screening, AI drug crystal-form prediction, AI pharmacokinetic and toxicological prediction, AI-assisted clinical trial design and patient recruitment, AI-enabled drug repurposing, multimodal AI foundation models for drug development, AI-driven pharmaceutical R&D data platforms, AI-assisted optimization of drug synthesis processes, and related fields.

Track 4: Smart Health Management and Proactive Health

Focus: Promoting the transformation of healthcare from “passive treatment” to “proactive prevention,” this track aims to establish a comprehensive and personalized health management system covering the entire life cycle, thereby reducing the incidence of chronic diseases and the overall healthcare burden.

Areas of Solicitation:Innovative projects in wearable health-monitoring devices (including real-time physiological monitoring and chronic disease management devices), predictive medical diagnosis systems, human digital twin platforms, age-friendly health products for the silver economy, intelligent chronic disease management systems, health risk early-warning and intervention solutions, proactive health service platforms, and related fields.

Ⅳ.REGISTRATION METHOD

Registration may be completed through either of the following methods:

1.Online registration on the official competition website: https://reg.gticcn.com/business/

2.Online registration on the special-track competition website: https://v.wjx.cn/vm/rSYaUMW.aspx

Ⅴ.COMPETITION PRIZES AND SUBSIDIES

1.In accordance with the overall requirements of the competition, awards will be established across all competition tracks. Prize money will be disbursed after the winning projects are officially implemented in Lucheng District.

First Prize: RMB 150,000 × 1 winner

Second Prize: RMB 100,000 × 2 winners

Third Prize: RMB 50,000 × 3 winners

2.Participation Subsidies: The Competition Organizing Committee will offer round-trip transportation subsidies and complimentary board and lodging to projects attending the Grand Final in Lucheng District, Wenzhou. The subsidy cap is RMB 10,000 per person for Europe and America, RMB 3,500 per person for Asia, RMB 2,000 per person for other domestic regions, and RMB 1,000 per person within Zhejiang Province. International participants must enter China and arrive in Wenzhou within 7 days, while domestic participants shall arrive within 3 days. Only economy class tickets are reimbursable.